BIOMAT Database Logo BIOMAT Database Logo

Quercetin inhibits the growth of a multidrug-resistant estrogen-receptor-negative MCF-7 human breast-cancer cell line expressing type II estrogen-binding sites. 1991

G Scambia, and F O Ranelletti, and P Benedetti Panici, and M Piantelli, and G Bonanno, and R De Vincenzo, and G Ferrandina, and L Pierelli, and A Capelli, and S Mancuso
Department of Gynecology, Catholic University, Largo A. Gemelli, Rome.

It has been demonstrated that the flavonoid quercetin (3,3',4',5,7-pentahydroxyflavone; Q) inhibits the growth of several cancer cell lines. There is evidence suggesting that the antiproliferative activity of this substance is mediated by the so-called type II estrogen-binding site (type II EBS). We looked for the presence of type II EBS and the effect of Q on the proliferation of an Adriamycin-resistant estrogen-receptor-negative human breast-cancer cell line (MCF-7 ADRr). By whole-cell assay using estradiol labelled with 6,7-tritium [( 3H]-E2) as a tracer, we demonstrated that MCF-7 ADRr cells contain type II EBSs. Competition analysis revealed that diethylstilbestrol (DES) and Q competed with similar potency for [3H]-Es binding to type II EBSs. The antiestrogen tamoxifen (TAM) competed for type II EBSs, albeit to a lesser extent than either DES or Q. Growth experiments demonstrated that Q and DES exerted a dose-dependent inhibition of cell proliferation in the range of concentrations between 10 nM and 10 microM, whereas TAM was less effective. Q could also inhibit colony formation in a clonogenic assay. Our results indicate that multidrug-resistant estrogen-receptor-negative MCF-7 cells express type II EBSs and are sensitive to the inhibitory effect of Q. This substance could be the parent compound of a novel class of anticancer agents.

UI MeSH Term Description Entries
D011794 Quercetin A flavonol widely distributed in plants. It is an antioxidant, like many other phenolic heterocyclic compounds. Glycosylated forms include RUTIN and quercetrin. 3,3',4',5,7-Pentahydroxyflavone,Dikvertin
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003864 Depression, Chemical The decrease in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical. Chemical Depression,Chemical Depressions,Depressions, Chemical
D004054 Diethylstilbestrol A synthetic nonsteroidal estrogen used in the treatment of menopausal and postmenopausal disorders. It was also used formerly as a growth promoter in animals. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), diethylstilbestrol has been listed as a known carcinogen. (Merck, 11th ed) Stilbestrol,Agostilben,Apstil,Diethylstilbestrol, (Z)-Isomer,Diethylstilbestrol, Disodium Salt,Distilbène,Stilbene Estrogen,Tampovagan,Estrogen, Stilbene
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug

Related Publications

G Scambia, and F O Ranelletti, and P Benedetti Panici, and M Piantelli, and G Bonanno, and R De Vincenzo, and G Ferrandina, and L Pierelli, and A Capelli, and S Mancuso
Estrogen Sulfotransferase Induction Inhibits Breast Cancer Cell Line MCF-7 Proliferation.
January 2019, Biomedical journal of scientific & technical research,
G Scambia, and F O Ranelletti, and P Benedetti Panici, and M Piantelli, and G Bonanno, and R De Vincenzo, and G Ferrandina, and L Pierelli, and A Capelli, and S Mancuso
The antiandrogen flutamide inhibits growth of mcf-7 human breast-cancer cell-line.
April 1993, International journal of oncology,
G Scambia, and F O Ranelletti, and P Benedetti Panici, and M Piantelli, and G Bonanno, and R De Vincenzo, and G Ferrandina, and L Pierelli, and A Capelli, and S Mancuso
17beta-Estradiol inhibits osteoprotegerin production by the estrogen receptor-alpha-positive human breast cancer cell line MCF-7.
April 2008, Biochemical and biophysical research communications,
G Scambia, and F O Ranelletti, and P Benedetti Panici, and M Piantelli, and G Bonanno, and R De Vincenzo, and G Ferrandina, and L Pierelli, and A Capelli, and S Mancuso
Estrogen receptor in a human cell line (MCF-7) from breast carcinoma.
September 1973, The Journal of biological chemistry,
G Scambia, and F O Ranelletti, and P Benedetti Panici, and M Piantelli, and G Bonanno, and R De Vincenzo, and G Ferrandina, and L Pierelli, and A Capelli, and S Mancuso
Cell cycle analysis of estrogen stimulated growth of the human breast cancer cell line, MCF-7.
April 1986, European journal of cancer & clinical oncology,
G Scambia, and F O Ranelletti, and P Benedetti Panici, and M Piantelli, and G Bonanno, and R De Vincenzo, and G Ferrandina, and L Pierelli, and A Capelli, and S Mancuso
Estrogen stimulates adenosine receptor expression subtypes in human breast cancer MCF-7 cell line.
February 2018, Research in pharmaceutical sciences,
G Scambia, and F O Ranelletti, and P Benedetti Panici, and M Piantelli, and G Bonanno, and R De Vincenzo, and G Ferrandina, and L Pierelli, and A Capelli, and S Mancuso
Altered regulation of P-450IA1 expression in a multidrug-resistant MCF-7 human breast cancer cell line.
December 1988, The Journal of biological chemistry,
G Scambia, and F O Ranelletti, and P Benedetti Panici, and M Piantelli, and G Bonanno, and R De Vincenzo, and G Ferrandina, and L Pierelli, and A Capelli, and S Mancuso
Differential expression of estrogen receptor mRNA splice variants in the tamoxifen resistant human breast cancer cell line, MCF-7/TAMR-1 compared to the parental MCF-7 cell line.
April 1995, Molecular and cellular endocrinology,
G Scambia, and F O Ranelletti, and P Benedetti Panici, and M Piantelli, and G Bonanno, and R De Vincenzo, and G Ferrandina, and L Pierelli, and A Capelli, and S Mancuso
Regulation of epidermal growth factor-receptor by estrogen and antiestrogen in the human breast cancer cell line MCF-7.
February 1989, Biochemical and biophysical research communications,
G Scambia, and F O Ranelletti, and P Benedetti Panici, and M Piantelli, and G Bonanno, and R De Vincenzo, and G Ferrandina, and L Pierelli, and A Capelli, and S Mancuso
An insulin effect on cytoplasmic estrogen receptor in the human breast cancer cell line MCF-7.
April 1981, The Journal of biological chemistry,
Copied contents to your clipboard!